INSIGHTS ON SOLID DOSE MANUFACTURING
-
Developing And Manufacturing Drugs With HPAPIs
Learn why companies must invest in specialized expertise to develop scalable, safe, and efficient manufacturing processes for highly potent oral solid dose products.
-
Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets
Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.
-
How To Achieve Late-Phase Success In Complex OSD Development
Late-phase OSD scale-up demands more than technical know-how. This paper examines the frameworks, tools, and partnership models that determine whether promising molecules reach commercial production reliably.
-
Advancing High Potency Manufacturing
Advance potent drug manufacturing through tighter containment, thoughtful process engineering, and closed handling that protects workers while improving efficiency and scale.
-
Almac Pharma Services Capabilities Update November 2026: Bioavailability And Solubility11/18/2026
Optimize bioavailability with biorelevant solubility, dissolution, and in vitro permeability testing to guide bioenhancement strategies and formulation development.
-
Breaking The GLP-1 Manufacturing Bottleneck: Single Use For Safer Scale Up9/23/2026
Streamline GLP-1 scale-up by replacing heavy container cleaning with single-use powder handling to boost containment and manufacturing capacity.
-
Cytiva's Aseptic Filling Workcell User Group1/9/2026
Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.
-
Predicting Food Effects In Oral Drug Delivery Using PBPK Modeling7/15/2026
Learn how integrated PBPK and molecular dynamics modeling predicted an ~11% fed-state Cmax increase for fenofibrate, giving formulation teams earlier, mechanistic insight into food-dependent absorption.
-
From Disruption To Reinvention: The Story Of API-In-Capsule Technology And Its Future8/19/2025
Discover how advanced API-in-capsule technology addresses previous limitations, providing a flexible and efficient path for drug candidates from development to clinical trials.
SOLID DOSE MANUFACTURING SOLUTIONS
-
The aseptic/sterile Fill-Finish equipment solutions need to be cGMP compliant, dependable and accurately designed to comply with the most recent revisions of the “Annex 1 Manufacture of Sterile Medicinal Products guidelines”. Newly designed equipment needs to accommodate for small batches, various speeds and containers, including RTU / RTF (Ready To Use or Ready To Fill) bottles, vials, cartridges, syringes and pre-sterile nested trays. Moreover, the filling equipment solution should also improve the ergonomic use for operators and maximize cleanroom efficiency.
-
An oral solid pilot plant paired with pharmaceutical technology and analytical development labs, built inside a commercial production campus, supports work through clinical batches and small-scale commercial supply.
-
Oral solid dose manufacturing supports complex formulations with flexible scales, specialized technologies, and integrated packaging for reliable clinical and commercial supply.
-
Providing customized solid-dose bottling solutions with agile production for a wide range of bottle sizes and shapes, flexible quantity requirements, and multiple cap types.
-
Oral dose development, manufacturing, packaging, and serialization under one quality system, supporting potent and controlled compounds from clinical supply through commercial launch.